Vivos Therapeutics (VVOS) Goodwill & Intangibles (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Goodwill & Intangibles data on file, last reported at $12.4 million in Q1 2026.

• On a quarterly basis, Goodwill & Intangibles rose 293.89% year-over-year to $12.4 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 293.89% increase from a year earlier, with the FY2025 full-year figure at $12.6 million, up 293.18% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $12.4 million, down from $12.6 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for VVOS reached as high as $12.6 million in Q4 2025 and fell as low as $3.1 million in Q4 2022.
• Historically, Goodwill & Intangibles has averaged $5.2 million across 5 years, with a median of $3.2 million in 2024.
• Across the five-year window, Goodwill & Intangibles slumped 40.98% in 2022 and jumped 293.89% in 2026, its largest moves.
• Year by year, Goodwill & Intangibles stood at $3.1 million in 2022, then advanced by 2.38% to $3.2 million in 2023, then dropped by 0.34% to $3.2 million in 2024, then soared by 293.18% to $12.6 million in 2025, then slipped by 1.41% to $12.4 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $12.4 million in Q1 2026, $12.6 million in Q4 2025, and $10.7 million in Q3 2025.